Companies: 10,795·Total market cap: $144.5T
BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd.

BVXVNASDAQHealthcare
$1.36
+$0.01(+0.74%)
Market Cap$4966625
P/E Ratio—
52W High$11.49
52W Low$0.63
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

BiondVax Pharmaceuticals Ltd. (BVXV) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001611747 · BVXV · NASDAQ · as of Jun 9, 2026

Filing snapshot

474
Total Filings
6-K
Latest Form
2026-06-08
Most Recent
2015
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001611747 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-04-01
Fiscal Year End
Apr 1, 2026
Accession No.
0001213900-26-038011
Primary Document
ea0283609-20f_scinai.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001611747 · Accession 0001213900-26-038011

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-08
View 6-K on SEC
8-KCurrent Report
CURRENT REPORT
2023-06-08Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-08
View
EFFECTEFFECT
EFFECT
2026-05-19
View
424B3424B3
PROSPECTUS
2026-05-19
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-12
View
F-3F-3
REGISTRATION STATEMENT
2026-05-08
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-08
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-27
View
20-FAnnual Report (Foreign Issuer)
ANNUAL REPORT
2026-04-01
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-03-26
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-23
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-19
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-03-18
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-03-18
View
Showing 1–15 of 474 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001611747  |  Exchange: NASDAQ · Healthcare

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) has submitted 474 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001611747, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is BiondVax Pharmaceuticals Ltd.'s most comprehensive regulatory disclosure. The most recent BiondVax Pharmaceuticals Ltd. 10-K was filed on 2026-04-01 for fiscal year ending 2026. Historical BVXV 10-K annual reports are available from 2014 through 2026.

Investors researching BiondVax Pharmaceuticals Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
TECX SEC Filings →NEUP SEC Filings →TNFA SEC Filings →TCDA SEC Filings →FRTX SEC Filings →APTO SEC Filings →GMDA SEC Filings →HILS SEC Filings →
→ BVXV Financials→ BVXV Earnings→ BVXV Insider Trades

Frequently Asked Questions

BVXV SEC Filings · 8 questions

BiondVax Pharmaceuticals Ltd. (BVXV) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 474 filings and access original documents at no cost. BiondVax Pharmaceuticals Ltd.'s CIK is 0001611747.

BVXV SEC filingsBiondVax Pharmaceuticals Ltd. SEC documentsfind BVXV 10-K